These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1973334)
1. Current status and future goals of the pharmacologic reduction of portal hypertension. Lebrec D Am J Surg; 1990 Jul; 160(1):19-25. PubMed ID: 1973334 [TBL] [Abstract][Full Text] [Related]
2. Long-term pharmacologic therapy of portal hypertension. Burroughs AK; McCormick PA Surg Clin North Am; 1990 Apr; 70(2):319-39. PubMed ID: 1969683 [TBL] [Abstract][Full Text] [Related]
8. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642 [TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301 [TBL] [Abstract][Full Text] [Related]
10. Beta-blockers in portal hypertension: new developments and controversies. Tripathi D; Hayes PC Liver Int; 2014 May; 34(5):655-67. PubMed ID: 24134058 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985 [TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study. Hobolth L; Bendtsen F; Hansen EF; Møller S Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869 [TBL] [Abstract][Full Text] [Related]
13. [The effect of propranolol on portal hypertension]. Kovacević N; Tomić D; Perisić-Savić M; Grbić R Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814 [TBL] [Abstract][Full Text] [Related]
18. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222 [TBL] [Abstract][Full Text] [Related]
19. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283 [TBL] [Abstract][Full Text] [Related]